Dagodog, Cesanie P.
HRN: 23-76-42 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/18/2025
CEFUROXIME 750MG (VIAL)
02/18/2025
02/25/2025
IV
300mg
Q8
PCAP C
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: PneumoniaBloodstreamProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes